Here, we used human and fly models, a number of in vitro and in vivo assays including Ca2+ imaging together with novel pharmacological manipulation to identify a role for the lysosomal cation channel two-pore channel-2 (TPC2) in Ca2+ dysfunction and dopaminergic deficiency in LRRK2 PD. Here, TPCN2 is linked to Parkinson disease.